OMKARCHEM

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'The Resource Committee Meeting of the Company was held on April 16, 2018. The members ofthe committee discussed the matter regarding Bank of Baroda having declared the LoanAccount of the Company as Non-Performing Asset. The members discussed in length and theCompany is working on a suitable solution to address this matter.'.

Pravin S. Herlekar has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'FILING OF A PATENT APPLICATION'.

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated February 20, 2018 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone limited review report not submitted. -2. Segment details not submitted. The response of the Company is enclosed.

The Exchange has sought clarification from Omkar Speciality Chemicals Limited for financial results submitted for quarter ended September 30, 2017,����with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted.�� The response of the Company is enclosed.

Omkar Speciality Chemicals Limited has informed the Exchange regarding a press release dated February 12, 2018, titled "PRESS RELEASE �� REG. 30".

Pravin Shivdas Herlekar has submitted to the Exchange, vide letter dated February 09, 2018 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Exchange had sought clarification from Omkar Speciality Chemicals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Reconciliation of profit and loss not submitted. The response of the Company is enclosed.

The Exchange has sought clarification from Omkar Speciality Chemicals Limited for financial results submitted for quarter ended December 31, 2017, with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted. -2. Segment details not submitted. The response of the Company is awaited.

The Exchange has sought clarification from Omkar Speciality Chemicals Limited for financial results submitted for quarter ended September 30, 2017,����with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted.�� The response of the Company is awaited.

Omkar Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

Omkar Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'Grant of Patent'.

Pravin S. Herlekar has submitted to the Exchange Regulation 10(6) �� Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 respect of acquisition under Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Omkar Speciality Chemicals Limited has submitted to the Exchange, vide letter dated January 03, 2018 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'RENEWAL OF PATENTS'.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'Intimation as per Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.'.

Omkar Speciality Chemicals Limited has informed the Exchange that regarding the meeting of Board of Directors of the Company, on December 14, 2017 to consider, approve and take on record the Unaudited Financial Results for quarter and half year ended on September 30,2017 and to take note of the Limited Review Report thereon, the company would now like to inform that the meeting of Board of Directors held on December 14, 2017 stood Adjourned for the want of quorum and other unavoidable circumstances within the scheduled time. The Chairman of the Board, with the approval of all the Directors of

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'Intimation Regarding Submission Of Financial Results For The Quarter / Half Year Ended September 30, 2017 Under Regulation 33(3) Of Sebi (Listing Obligations And Disclosure Requirements) Regulations, 2015.'.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'Clarification On Credit Rating Posted On Brickworks Ratings.'.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'GRANT OF PATENT FOR "PROCESS FOR TERMINAL DIHALOALKANE"'.

Omkar Speciality Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2017. Further, the company has informed the Exchange regarding voting results.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2017

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'Listing of Equity Shares of Lasa Supergenerics Limited'.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'Listing of Equity Shares of Lasa Supergenerics Limited'.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Transcript of Conference Call.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 27, 2017

Omkar Speciality Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2017.

Omkar Speciality Chemicals Limited has informed the Exchange regarding ' Renewal of Recognition of in-house R&D Unit of the Company'.

Omkar Speciality Chemicals Limited has informed the Exchange regarding 'In-Principle approval for listing of 22,864,449 Equity Shares of Rs.10/- each of Lasa Supergenerics Ltd. pursuant to Composite Scheme of Arrangement.'.

Omkar Speciality Chemicals Limited has submitted to the Exchange a Copy of Presentation on the financial performance of the Company for the Quarter ended June 30, 2017.

The Exchange has sought clarification from Omkar Speciality Chemicals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.On basis of above the Company is required to clarify. -1. Reconciliation of profit and loss not submitted.The response of the Company is awaited.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2017.

Omkar Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2017.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Omkar Speciality Chemicals Limited has informed the Exchange regarding Intimation under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 26, 2017.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Intimation under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Omkar Speciality Chemicals Limited has informed the Exchange that the company has been able to successfully tie-up the business for its upcoming launches with major global business players.

Omkar Speciality Chemicals Limited has informed the Exchange regarding The Composite Scheme of Arrangement- Allotment of Equity Shares by Lasa Supergenerics Limited (Resulting Company).

Omkar Speciality Chemicals Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update

Omkar Speciality Chemicals Limited has informed the Exchange that regarding a Filing of A Patent Application for a Novel Process for Coumarin.

Omkar Speciality Chemicals Limited has informed the Exchange that the Management would like to inform all stake holders that the Company has framed concrete plans for its business expansion by scaling up its activities in the existing segments like pharmaceuticals and related areas. The Company would further like to penetrate into segments like fragrances & flavours, foods & beverages, etc. in which new products will be launched in immediate future. These products will be having end application in FMCG sector. The Company has already tapped opportunities in these segments in domestic and overs

Omkar Speciality Chemicals Limited has informed the Exchange that Mr.Pravin Agrawal, Chief Financial Officer, Chief Investor Relation Officer and Key Managerial Personnel of the Company has relinquished charge of the said position in the Company w.e.f. closure of business hours of June 30, 2017 to look for new career opportunities.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Cost Of Acquisition of the shares of Omkar Speciality Chemicals Limited and Lasa Supergenerics Limited.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 16, 2017.

Omkar Speciality Chemicals Limited has informed the Exchange that the Company has fixed Record Date as June 13, 2017 for the purpose of determining shareholders of Omkar Speciality Chemicals Limited to whom equity share of Lasa Supergenerics Limited ( Resulting Company) shall be allotted pursuant to the said scheme.

Omkar Speciality Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Omkar Speciality Chemicals Limited has submitted to the Exchange a copy of Transcript of Conference Call .